Companies

Progyny, Inc.

PGNY · CIK 0001551306 · operating

$17.61-0.48%Last updated Mar 2, 7:07 PM

Key Statistics

Valuation

Market Cap$1.53B
P/E28.66
Fwd P/E8.31
PEG
P/S1.19
P/B2.85
EV/EBITDA11.91
EV/Rev0.91

Profitability

Gross Margin24.15%
Op. Margin4.78%
Net Margin3.92%
ROE2.42%
ROA1.68%
FCF Margin60.23%

Financial Health

Current Ratio2.73
Debt/Equity0.44
Free Cash Flow$191.78M
Div. Yield

Growth & Other

Revenue Growth6.69%
EPS Growth16.67%
Beta1.01
52W High$28.75
52W Low$16.755

About Progyny, Inc.

Progyny operates as a benefits management company specializing in fertility, family building, and women's health solutions for employers and their employees in the United States. The company provides differentiated fertility benefits plan design, including its smart cycle treatment bundle, alongside personalized concierge-style member support services and access to a selective network of fertility specialists. Progyny also operates Progyny Rx, an integrated pharmacy benefits solution that supplies medications required during treatment and offers associated care management services.

The company's service offerings extend beyond core fertility treatment to include an assistance service program covering adoption reimbursement, surrogacy support, doula services, and travel reimbursement for cases where travel is necessary to access medical care. This diversified approach to family building benefits differentiates its positioning within the health benefits space.

Progyny operates with a workforce of approximately 675 full-time employees and maintains headquarters in New York, New York. The company was incorporated in 2008 as Auxogyn, Inc. before adopting its current name in 2015 and is listed on the Nasdaq exchange.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$0.14$0.15+16.7%
2024$0.12$0.12-7.7%
2023$0.13$0.14+333.3%
2022$0.03$0.04-80.0%
2021$0.15$0.17-61.5%
2020$0.39$0.45+195.1%
2019$-0.41$-0.41

Annual Reports (10-K) · 7 filings

Report DateFiledAccession Number
2025-12-312026-02-270001551306-26-000020SEC ↗
2024-12-312025-03-030001551306-25-000040SEC ↗
2023-12-312024-02-290001551306-24-000031SEC ↗
2022-12-312023-03-010001551306-23-000015SEC ↗
2021-12-312022-03-010001558370-22-002466SEC ↗
2020-12-312021-03-010001558370-21-002082SEC ↗
2019-12-312020-03-100001558370-20-002258SEC ↗